For clinical AKI still ongoing at time of organ procurement, however, ten biomarkers were significantly different- EGF, NGAL, cystatin-C, MCP-1, LFABP, UMOD, UACR, IL-8, YKL-40, and IL-6 (Table 4). This evidence concerns the gene CHI3L1 and acute kidney injury.